Health Care & Life Sciences » Biotechnology | Charles River Laboratories International Inc.

Charles River Laboratories International Inc.

Charles River Laboratories International Inc.
Stock Exchange New York Stock Exchange
EPS
$4.65
Market Cap
$6.94 B
Shares Outstanding
48.75 M
Public Float
47.32 M

Profile

Address
251 Ballardvale Street
Wilmington Massachusetts 01887
United States
Employees -
Website http://www.criver.com
Updated 07/08/2019
Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following business segments: Research Models & Services, Discovery & Safety Assessment, and Manufacturing Support. The Research Models & Services segment comprises of the production and sale of research models, and also offers services designed to support its client's use of research models in screening non-clinical drug candidates.

Financials

View All

James C. Foster
Chairman, President & Chief Executive Officer
Jean-Paul Mangeolle
Independent Director